Evidence map›Paper›PMID 42421936›Full record

ArticleFrontiers in immunology2026

Case Report: Primary hemophagocytic lymphohistiocytosis with a homozygous PRF1 variant: a case suggesting early immunoporosis and an expanded phenotypic spectrum.

Eman T Al-Antary, Avanti Gupte, Süreyya Savaşan

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eman T Al-Antary *Division of Hematology/Oncology, Children's Hospital of Michigan, Detroit, MI, United States.
Avanti Gupte *Division of Hematology/Oncology, Children's Hospital of Michigan, Detroit, MI, United States.
Süreyya Savaşan *Division of Hematology/Oncology, Children's Hospital of Michigan, Detroit, MI, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial HLH is an autosomal recessive condition characterized by mutations in genes responsible for the secretory lysosome-dependent exocytosis pathway. Its diagnosis is often challenging to complex clinical presentation, and prompt treatment is essential to avoid fatal outcomes. We describe a novel PRF1 mutation variant p.Y296C c.887 A>G in a pediatric patient with familial HLH (FHL2), which has not yet been reported in the literature to be associated with primary HLH. In this case, we also hypothesize that the phenomenon of immunoporosis contributed to the significant skeletal muscle findings reported in our patient.

Indexed as

Lymphohistiocytosis, HemophagocyticMutationPerforinAdolescentHomozygoteHumansMalePhenotypePerforinPRF1 protein, humanHLH - hemophagocytic lymphohistiocytosisHSCT = hematopoietic stem cell transplantimmunoporosispediatricPRF1 mutation

Identifiers

PMID42421936
PMCPMC13341474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.